Editorial: N.Z. and S.S.P.E.
D000293:Adolescent; D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology*; D008459:Measles virus / Q000276:immunology; D008875:Middle Aged; D009520:New Zealand; D011054:Poliovirus Vaccine, Inactivated / Q000009:adverse effects*; D013539:Simian virus 40 / Q000276:immunology; D013344:Subacute Sclerosing Panencephalitis / Q000453:epidemiology / Q000209:etiology* / Q000276:immunology / Q000382:microbiology
D000914:Antibodies, Viral; D011054:Poliovirus Vaccine, Inactivated